Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C
Sponsor: Addpharma Inc.
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C
Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-06
Completion Date
2026-07
Last Updated
2026-05-15
Healthy Volunteers
Yes
Conditions
Interventions
AD-231
AD-231 Oral Tablet
AD-231A, AD-231D and AD-231C
AD-231A Oral Tablet + AD-231D Oral Tablet + AD-231C Oral Tablet
Locations (1)
H Plus Yangji Hospita
Seoul, South Korea